At least one child has died due to mystery strain of ‘acute, severe’ hepatitis, WHO says

At least 169 cases of the disease reported in children in 12 countries, including the UK

Vishwam Sankaran
Monday 25 April 2022 08:36
Comments
US warns doctors to look for hepatitis in children as probe widens

A severe hepatitis disease of unknown origin found in 12 countries has led to the death of at least one child, said the World Health Organisation (WHO).

At least 169 cases of the acute viral hepatitis disease have been reported in children aged from a month to 16 years old in countries including the UK, the US, Spain, Italy, and France, the UN health agency said on Saturday.

At least one death was reported from the “acute, severe” hepatitis strain that has led to 17 children (approximately 10 per cent) requiring liver transplantation, the agency pointed out.

It is as yet unclear if there has been an increase in hepatitis cases, or a rise in awareness of hepatitis cases that occur at the expected rate but go undetected, according to the WHO.

The causative agent behind the reported cases also remains unknown.

Symptoms from the disease include markedly elevated liver enzymes along with reports of many suffering gastrointestinal symptoms including abdominal pain, diarrhoea and vomiting, preceding presentation with severe acute hepatiti and jaundice, the WHO said.

Fever was not reported in most of the cases, the UN body said.

Reports suggest patients have levels of liver enzymes aspartate transaminase (AST) or alanine aminotransaminase (ALT) greater than 500 international units per litre (IU/L).

For comparison, normal levels of AST and ALT in children fall in the range of 10-40 (IU/L).

Common viruses that cause acute viral hepatitis, including hepatitis viruses A, B, C, D and E, have not been detected in any of these cases, but adenovirus has been detected in at least 74 cases.

Eighteen of the cases have been identified as F type 41.

About 20 cases were detected with a co-infection of Covid and adenovirus, the WHO noted.

While adenovirus is one of the suspected causes of the reported cases, WHO said it “does not fully explain the severity of the clinical picture”.

“Infection with adenovirus type 41, the implicated adenovirus type, has not previously been linked to such a clinical presentation,” it added.

While past cases of hepatitis in immunocompromised children with adenovirus infection were reported, the WHO said the particular adenovirus type 41 is not known to be a cause of hepatitis in otherwise healthy children.

Experts also pointed out that the increased reported prevalence of adenovirus may be due to enhanced laboratory testing for the virus.

With further work needed to identify additional cases across the globe, the UN body said the current priority is to determine the cause of these cases to further refine control and prevention actions.

“Other infectious and non-infectious explanations need to be excluded to fully assess and manage the risk,” the WHO noted.

It encouraged member states to follow prevention measures for adenovirus and other common infections, including regular hand washing and respiratory hygiene, as well as to identify, investigate and report potential cases fitting the case definition.

“Epidemiological and risk factor information should be collected and submitted by the Member States to WHO and partner agencies through agreed reporting mechanisms. Any epidemiological links between or among the cases might provide clues for tracking the source of illness,” the WHO said.

It recommended the testing of blood, serum, urine, stool, and respiratory samples, as well as liver biopsy samples in suspected patients with further virus characterisation including genome sequencing.

The UN body said it does not recommend any restriction on travel and/or trade with the UK or any other country where cases are identified, based on the currently available information.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in